Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.

 
Web www.patentalert.com

< Method and system for stimulating a dorsal root ganglion

> Modulation of gamma delta T cells to regulate airway hyperresponsiveness

> Substituted oxazolidinones and their use in the field of blood coagulation
~ 00540